<DOC>
	<DOCNO>NCT00138775</DOCNO>
	<brief_summary>The goal present study evaluate effect D-serine , add antipsychotic treatment , negative cognitive symptom schizophrenia . The investigator hypothesize D-serine improve cognitive function negative symptom .</brief_summary>
	<brief_title>Israel Multicenter D-Serine Study ( IMSER ) Treatment Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<criteria>Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) diagnosis schizophrenia and\or schizoaffective disorder . Age 18 64 . PANSS negative symptom score high 19 . SAS total score lower 12 . CDSS suicidal risk low 2 Epilepsy Meets DSMIV criterion mental retardation . Medical condition confounds presentation treatment ( e.g . uncontrolled diabetes mellitus , history kidney stone , acute drug toxicity , dementia , delirium , stroke , etc . ) Meets DSMIV criterion alcohol drug dependence last 6 month . Meets DSMIV criterion alcohol drug abuse last one month . Treatment clozapine . Current positive pregnancy test use acceptable method birth control . Meets DSMIV criterion current anxiety mood disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>D-serine</keyword>
	<keyword>Negative symptom</keyword>
	<keyword>Cognition</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Amino acid</keyword>
</DOC>